Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumours (MK-7902-005/E7080-G000-224/LEAP-005)

Show: Show only recruiting locations

Trial Centre	Location	Province	Status
BC Cancer Agency - Abbotsford Centre	Abbotsford	British Columbia	Closed
32900 Marshall Road Abbotsford, British Columbia V2S 0C2 [View Map]
CancerCare Manitoba	Winnipeg	Manitoba	Closed
Danielle Desautels, 204-787-2197 675 McDermot Ave. Winnipeg, Manitoba R3E 0V9 [View Map]
Hamilton Health Sciences	Hamilton	Ontario	Closed
699 Concession St. Hamilton, Ontario L8V 5C2 [View Map]
Princess Margaret Cancer Centre	Toronto	Ontario	Closed
610 University Avenue Toronto, Ontario M5G 2M9 [View Map]
Sunnybrook Health Sciences Centre	Toronto	Ontario	Closed
2075 Bayview Avenue Toronto, Ontario M4N 3M5 [View Map]
CHU de Québec - Université Laval - L'Hôtel-Dieu de Québec	Quebec	Quebec	Closed
Mme Maryse Gingras 418-691-5781 Dr Maxime Chénard-Poirier, MD 418-525-4444 11, côte du Palais Quebec, Quebec G1R 2J6 [View Map]
CHUM - Nouveau Centre Hospitalier Universitaire de Montréal	Montreal	Quebec	Closed
Dre Rahima Jamal, MD 514-890-8000 Ext. 20688 Mme Camille Amiel 514-890-8000 Ext. 30758 1051, rue Sanguinet Montreal, Quebec H2X 3E4 [View Map]

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

These resources are provided in partnership with the Canadian Cancer Society